Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Prepaid Assets (2020 - 2025)

Bolt Biotherapeutics' Prepaid Assets history spans 6 years, with the latest figure at $2.9 million for Q3 2025.

  • For Q3 2025, Prepaid Assets rose 13.88% year-over-year to $2.9 million; the TTM value through Sep 2025 reached $2.9 million, up 13.88%, while the annual FY2024 figure was $2.7 million, 1395.58% up from the prior year.
  • Prepaid Assets for Q3 2025 was $2.9 million at Bolt Biotherapeutics, up from $2.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.6 million in Q3 2021 and bottomed at $181000.0 in Q4 2023.
  • The 5-year median for Prepaid Assets is $3.7 million (2022), against an average of $3.9 million.
  • The largest annual shift saw Prepaid Assets plummeted 95.31% in 2023 before it soared 1395.58% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $2.9 million in 2021, then surged by 31.18% to $3.9 million in 2022, then tumbled by 95.31% to $181000.0 in 2023, then skyrocketed by 1395.58% to $2.7 million in 2024, then rose by 7.57% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for BOLT's Prepaid Assets are $2.9 million (Q3 2025), $2.8 million (Q2 2025), and $2.9 million (Q1 2025).